vs
爱玛客（ARMK）与汉瑞祥（HSIC）财务数据对比。点击上方公司名可切换其他公司
爱玛客的季度营收约是汉瑞祥的1.4倍（$4.8B vs $3.4B），汉瑞祥净利率更高（2.9% vs 2.0%，领先0.9%），汉瑞祥同比增速更快（7.7% vs 6.1%），汉瑞祥自由现金流更多（$338.0M vs $-904.4M），过去两年爱玛客的营收复合增速更高（7.3% vs 4.1%）
爱玛客是美国知名的餐饮服务与设施管理服务商，服务覆盖教育、司法监管、医疗、企业、休闲文旅等多个领域，业务遍布北美地区及英国、德国、智利、爱尔兰、西班牙在内的14个国家，为各场景客户提供专业后勤支持解决方案。
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
ARMK vs HSIC — 直观对比
营收规模更大
ARMK
是对方的1.4倍
$3.4B
营收增速更快
HSIC
高出1.6%
6.1%
净利率更高
HSIC
高出0.9%
2.0%
自由现金流更多
HSIC
多$1.2B
$-904.4M
两年增速更快
ARMK
近两年复合增速
4.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.8B | $3.4B |
| 净利润 | $96.2M | $101.0M |
| 毛利率 | — | 30.9% |
| 营业利润率 | 4.5% | 4.7% |
| 净利率 | 2.0% | 2.9% |
| 营收同比 | 6.1% | 7.7% |
| 净利润同比 | -9.0% | 7.4% |
| 每股收益（稀释后） | $0.36 | $0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARMKHSIC
| Q1 26 | $4.8B | — | ||
| Q4 25 | $5.0B | $3.4B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | $4.6B | $3.2B | ||
| Q1 25 | $4.3B | $3.2B | ||
| Q4 24 | $4.6B | $3.2B | ||
| Q3 24 | $4.4B | $3.2B | ||
| Q2 24 | $4.4B | $3.1B |
净利润ARMKHSIC
| Q1 26 | $96.2M | — | ||
| Q4 25 | $87.1M | $101.0M | ||
| Q3 25 | — | $101.0M | ||
| Q2 25 | $71.8M | $86.0M | ||
| Q1 25 | $61.9M | $110.0M | ||
| Q4 24 | $105.6M | $94.0M | ||
| Q3 24 | $122.4M | $99.0M | ||
| Q2 24 | $58.1M | $104.0M |
毛利率ARMKHSIC
| Q1 26 | — | — | ||
| Q4 25 | — | 30.9% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 31.1% | ||
| Q3 24 | — | 31.3% | ||
| Q2 24 | — | 32.5% |
营业利润率ARMKHSIC
| Q1 26 | 4.5% | — | ||
| Q4 25 | 4.3% | 4.7% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | 3.9% | 4.7% | ||
| Q1 25 | 4.1% | 5.5% | ||
| Q4 24 | 4.8% | 4.9% | ||
| Q3 24 | 5.0% | 4.9% | ||
| Q2 24 | 3.7% | 5.1% |
净利率ARMKHSIC
| Q1 26 | 2.0% | — | ||
| Q4 25 | 1.7% | 2.9% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | 1.6% | 2.7% | ||
| Q1 25 | 1.4% | 3.5% | ||
| Q4 24 | 2.3% | 2.9% | ||
| Q3 24 | 2.8% | 3.1% | ||
| Q2 24 | 1.3% | 3.3% |
每股收益（稀释后）ARMKHSIC
| Q1 26 | $0.36 | — | ||
| Q4 25 | $0.33 | $0.85 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | $0.27 | $0.70 | ||
| Q1 25 | $0.23 | $0.88 | ||
| Q4 24 | $0.39 | $0.75 | ||
| Q3 24 | $0.46 | $0.78 | ||
| Q2 24 | $0.22 | $0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $439.6M | $156.0M |
| 总债务越低越好 | $6.2B | $2.3B |
| 股东权益账面价值 | $3.2B | $3.2B |
| 总资产 | $13.5B | $11.2B |
| 负债/权益比越低杠杆越低 | 1.94× | 0.71× |
8季度趋势，按日历期对齐
现金及短期投资ARMKHSIC
| Q1 26 | $439.6M | — | ||
| Q4 25 | $639.1M | $156.0M | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | $501.5M | $145.0M | ||
| Q1 25 | $920.5M | $127.0M | ||
| Q4 24 | $484.1M | $122.0M | ||
| Q3 24 | $672.5M | $126.0M | ||
| Q2 24 | $436.1M | $138.0M |
总债务ARMKHSIC
| Q1 26 | $6.2B | — | ||
| Q4 25 | $5.4B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $6.3B | $2.1B | ||
| Q1 25 | $6.1B | $2.0B | ||
| Q4 24 | $5.0B | $1.8B | ||
| Q3 24 | $4.3B | $1.9B | ||
| Q2 24 | $5.0B | $1.9B |
股东权益ARMKHSIC
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.1B | $3.2B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | $3.1B | $3.4B | ||
| Q1 25 | $3.0B | $3.3B | ||
| Q4 24 | $3.1B | $3.4B | ||
| Q3 24 | $3.0B | $3.5B | ||
| Q2 24 | $2.9B | $3.5B |
总资产ARMKHSIC
| Q1 26 | $13.5B | — | ||
| Q4 25 | $13.3B | $11.2B | ||
| Q3 25 | — | $11.1B | ||
| Q2 25 | $13.3B | $10.9B | ||
| Q1 25 | $13.5B | $10.5B | ||
| Q4 24 | $12.7B | $10.2B | ||
| Q3 24 | $12.7B | $10.6B | ||
| Q2 24 | $12.5B | $10.3B |
负债/权益比ARMKHSIC
| Q1 26 | 1.94× | — | ||
| Q4 25 | 1.71× | 0.71× | ||
| Q3 25 | — | 0.64× | ||
| Q2 25 | 2.03× | 0.61× | ||
| Q1 25 | 2.02× | 0.59× | ||
| Q4 24 | 1.61× | 0.54× | ||
| Q3 24 | 1.42× | 0.54× | ||
| Q2 24 | 1.71× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-782.2M | $381.0M |
| 自由现金流经营现金流 - 资本支出 | $-904.4M | $338.0M |
| 自由现金流率自由现金流/营收 | -18.7% | 9.8% |
| 资本支出强度资本支出/营收 | 2.5% | 1.3% |
| 现金转化率经营现金流/净利润 | -8.13× | 3.77× |
| 过去12个月自由现金流最近4个季度 | — | $573.0M |
8季度趋势，按日历期对齐
经营现金流ARMKHSIC
| Q1 26 | $-782.2M | — | ||
| Q4 25 | — | $381.0M | ||
| Q3 25 | — | $174.0M | ||
| Q2 25 | $76.7M | $120.0M | ||
| Q1 25 | $255.9M | $37.0M | ||
| Q4 24 | $-587.2M | $204.0M | ||
| Q3 24 | $1.0B | $151.0M | ||
| Q2 24 | $140.7M | $296.0M |
自由现金流ARMKHSIC
| Q1 26 | $-904.4M | — | ||
| Q4 25 | — | $338.0M | ||
| Q3 25 | — | $141.0M | ||
| Q2 25 | $-34.7M | $88.0M | ||
| Q1 25 | $140.1M | $6.0M | ||
| Q4 24 | $-707.0M | $168.0M | ||
| Q3 24 | $882.3M | $117.0M | ||
| Q2 24 | $55.6M | $259.0M |
自由现金流率ARMKHSIC
| Q1 26 | -18.7% | — | ||
| Q4 25 | — | 9.8% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | -0.8% | 2.7% | ||
| Q1 25 | 3.3% | 0.2% | ||
| Q4 24 | -15.5% | 5.3% | ||
| Q3 24 | 20.0% | 3.7% | ||
| Q2 24 | 1.3% | 8.3% |
资本支出强度ARMKHSIC
| Q1 26 | 2.5% | — | ||
| Q4 25 | 2.8% | 1.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | 2.4% | 1.0% | ||
| Q1 25 | 2.7% | 1.0% | ||
| Q4 24 | 2.6% | 1.1% | ||
| Q3 24 | 3.2% | 1.1% | ||
| Q2 24 | 1.9% | 1.2% |
现金转化率ARMKHSIC
| Q1 26 | -8.13× | — | ||
| Q4 25 | — | 3.77× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | 1.07× | 1.40× | ||
| Q1 25 | 4.14× | 0.34× | ||
| Q4 24 | -5.56× | 2.17× | ||
| Q3 24 | 8.35× | 1.53× | ||
| Q2 24 | 2.42× | 2.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARMK
| Education | $1.1B | 22% |
| Sports Leisure Corrections | $961.2M | 20% |
| Food And Support Services International | $847.8M | 18% |
| Other | $621.6M | 13% |
| Businessand Industry | $510.6M | 11% |
| Health Care | $421.3M | 9% |
| Facility Services | $382.9M | 8% |
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
